Your browser doesn't support javascript.
loading
Effect of levosimendan therapy on myocardial infarct size and left ventricular function after acute coronary occlusion.
Tarkia, Miikka; Stark, Christoffer; Haavisto, Matti; Kentala, Rasmus; Vähäsilta, Tommi; Savunen, Timo; Strandberg, Marjatta; Saunavaara, Virva; Tolvanen, Tuula; Teräs, Mika; Pietilä, Mikko; Nyman, Leena; Duvall, Emma; Saukko, Pekka; Levijoki, Jouko; Roivainen, Anne; Saraste, Antti; Knuuti, Juhani.
Afiliação
  • Tarkia M; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Department of Pharmacology, University of Helsinki, Helsinki, Finland.
  • Stark C; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Haavisto M; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
  • Kentala R; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  • Vähäsilta T; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
  • Savunen T; Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
  • Strandberg M; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
  • Saunavaara V; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
  • Tolvanen T; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
  • Teräs M; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
  • Pietilä M; Heart Center, Turku University Hospital and University of Turku, Turku, Finland.
  • Nyman L; Orion Corporation Orion Pharma, Espoo, Finland.
  • Duvall E; Quotient Bio Analytical Sciences, Fordham, UK.
  • Saukko P; Department of Forensic Medicine, University of Turku, Turku, Finland.
  • Levijoki J; Orion Corporation Orion Pharma, Espoo, Finland.
  • Roivainen A; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Turku Center for Disease Modeling, University of Turku, Turku, Finland.
  • Saraste A; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland Heart Center, Turku University Hospital and University of Turku, Turku, Finland Institute of Clinical Medicine, University of Turku, Turku, Finland.
  • Knuuti J; Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland.
Heart ; 102(6): 465-71, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26762238
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piridazinas / Função Ventricular Esquerda / Remodelação Ventricular / Oclusão Coronária / Hidrazonas / Contração Miocárdica / Infarto do Miocárdio / Miocárdio Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Heart Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Finlândia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Piridazinas / Função Ventricular Esquerda / Remodelação Ventricular / Oclusão Coronária / Hidrazonas / Contração Miocárdica / Infarto do Miocárdio / Miocárdio Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Animals Idioma: En Revista: Heart Assunto da revista: CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Finlândia